BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28714532)

  • 21. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
    Marin F; Murillo R; Diego C; Jodar E; Acevedo A
    Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.
    Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z
    Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
    Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core-needle biopsy versus repeat fine-needle aspiration for thyroid nodules initially read as atypia/follicular lesion of undetermined significance.
    Choi YJ; Baek JH; Suh CH; Shim WH; Jeong B; Kim JK; Song DE; Kim TY; Chung KW; Lee JH
    Head Neck; 2017 Feb; 39(2):361-369. PubMed ID: 27704650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat fine-needle aspiration can be performed at 6 months or more after initial atypia of undetermined significance or follicular lesion of undetermined significance results for thyroid nodules 10 mm or larger.
    Koh J; Kim EK; Kwak JY; Yoon JH; Moon HJ
    Eur Radiol; 2016 Dec; 26(12):4442-4448. PubMed ID: 26965502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
    Faquin WC; Baloch ZW
    Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
    Jeong SH; Hong HS; Lee EH; Cha JG; Park JS; Kwak JJ
    AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.
    Yoon JH; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2014 Jun; 155(6):1006-13. PubMed ID: 24630147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
    Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
    Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
    Suh YJ; Choi YJ
    Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients.
    Cho YY; Chung YJ; Kim HS
    Front Endocrinol (Lausanne); 2021; 12():745395. PubMed ID: 34659127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
    Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology with the deep convolutional neural network.
    Youn I; Lee E; Yoon JH; Lee HS; Kwon MR; Moon J; Kang S; Kwon SK; Jung KY; Park YJ; Park DJ; Cho SW; Kwak JY
    Sci Rep; 2021 Oct; 11(1):20048. PubMed ID: 34625636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy.
    Kuru B; Atmaca A; Kefeli M
    Diagn Cytopathol; 2016 May; 44(5):394-8. PubMed ID: 26917413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.
    Babajani A; Rahmani S; Raoufi M; Eidgahi ES; Dastjerdi AV; Behfarnia P; Khalili S; Moghaddam NA
    Front Endocrinol (Lausanne); 2023; 14():1135196. PubMed ID: 37313444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
    Lale SA; Morgenstern NN; Chiara S; Wasserman P
    Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid Atypia/Follicular Lesion of Undetermined Significance: Attitudes towards the Diagnosis of Bethesda System III Nodules.
    Estrada Muñoz L; Díaz Del Arco C; Ortega Medina L; Fernández Aceñero MJ
    Acta Cytol; 2017; 61(1):21-26. PubMed ID: 27852075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
    Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
    Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.